SCHEMBL6517410

SCHEMBL6517410

O=C1CCCN1CCCNc1ccc2c(=O)[nH]c3ncccc3c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.51
KDM4E B2RXH2 6/20 0.51
HSD17B10 Q99714 4/20 0.51
HPGD P15428 4/20 0.51
LMNA P02545 1/20 0.51
TSHR P16473 2/20 0.47
MAPT P10636 3/20 0.46
POLB P06746 1/20 0.46
MAPK1 P28482 1/20 0.46
GFER P55789 1/20 0.46
AURKA O14965 1/20 0.46
PARP1 P09874 1/20 0.46
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP3A4 P08684 1/20 0.45
RECQL P46063 1/20 0.45
MALT1 Q9UDY8 1/20 0.44
MKNK1 Q9BUB5 2/20 0.43
MKNK2 Q9HBH9 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6523008 0.81 PARP1 (0.51) AURKAPARP1
SCHEMBL6517375 0.77 AURKA (0.51) MAPTAURKAPARP1NPC1RAB9A
SCHEMBL6525014 0.76 RAD52 (0.59) GFERAURKAPARP1NPC1RAB9A
SCHEMBL6533053 0.74 AURKA (0.54) ALDH1A1KDM4EMAPTPOLBAURKA
SCHEMBL6525635 0.73 AURKA (0.56) ALDH1A1LMNATSHRAURKAPARP1
SCHEMBL6522568 0.73 PARP1 (0.46) ALDH1A1KDM4EHSD17B10TSHRMAPK1
SCHEMBL6524125 0.72 ELANE (0.48) ALDH1A1KDM4EHPGDMAPTMAPK1
SCHEMBL4553325 0.72 MALT1 (0.47) ALDH1A1KDM4EHSD17B10HPGDLMNA
SCHEMBL3454371 0.72 AURKA (0.60) MAPK1AURKAPARP1MKNK2
SCHEMBL7993255 0.72 ALDH1A1 (0.47) ALDH1A1KDM4EHSD17B10HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
WO-2009108670-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK SERONO S.A. (CH) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP4K2, MAP3K20, MAP4K1 ALDH1A1 4501/4885KDM4E 1872/4885HSD17B10 3888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.